In the present study, the close association between GSTM2 knockout and hepatic steatosis was examined by using GSTM2 -null mice
In summary, the rationale of employing DMF in psoriasis consists in reducing cellular inflammation both by decreasing glutathione intracellular levels and by inducing a switch in immune response toward an anti-inflammatory/immunoregulatory setting (68, 69)
Some considerations include: High cost per session Requirement for medical supervision Temporary effects requiring repeated treatments Potential discomfort from injections For many people, these factors make IV treatments impractical for long-term skincare routines
Clinical studies further support these findings, reporting mean maximum plasma concentrations (Cmax) of AS-IV at 2.12, 3.59, 3.71, and 5.17 g/mL following single doses of 200, 300, 400, and 500 mL of astragaloside injection (AI), respectively (Xu et al., 2013)